Albumin treatment of critical conditions on the example of pre-eclampsia
DOI:
https://doi.org/10.14739/2310-1210.2025.3.322667Keywords:
albumin, furosemide, inflammation index, interleukins, pre-eclampsiaAbstract
Despite the well-documented physicochemical and pharmacodynamic properties of albumin solutions and the availability of clinical guidelines for their use in critical conditions, several aspects of their application, particularly in the context of pre-eclampsia, remain a matter of clinical debate.
Aim: to ascertain the effect of intravenous human albumin solution on the inflammatory process activity in the postpartum period in women with pre-eclampsia.
Materials and methods. 60 women aged 18 to 40 years in the third trimester of pregnancy complicated by moderate or severe pre-eclampsia were assigned to 2 groups of 30 patients each according to the prespecified inclusion and exclusion criteria. Group I patients were given a standard therapy after delivery. Group II patients were treated with the same therapy combined with continuous infusions of 20 % albumin solution (8 ml/h – on day 1; 4 ml/h – on days 2 and 3) and furosemide (0.05 mg/kg/h – on day 1; 0.025 mg/kg/h – on days 2 and 3) for 72 hours. Serum concentrations of interleukins (IL)-6 and IL-10 were measured, and the IL-6 / IL-10 ratio (inflammation index) was calculated before the onset of labor, and on days 1 and 3 of the postpartum period.
Results. The analysis has shown the inflammatory index of 120 % higher the normal in the third trimester of uncomplicated pregnancy, indicating a slight prenatal increase in inflammatory processes. Moderate or severe pre-eclampsia in the same period has been found to be accompanied by significantly increased IL-6/IL-10 ratios by 523.3–570.0 %, showing the significant activation of inflammatory processes. The use of albumin infusion in combination with low doses of furosemide according to the method developed by us has proven the possibility to correct the inflammatory process activity. So, with infusions on the 1st day postpartum, the IL-6 / IL-10 ratio was decreased and exceeded the norm for non-pregnant women by 866.7 % versus 1696.7 % in Group 1 women. On the 3rd day after childbirth, the inflammatory index exceeded the norm by only 116.7 % with intravenous albumin, while in Group 1 (control), it remained 730.0 % higher than the norm.
Conclusions. Intravenous combination of albumin solution with furosemide in the postpartum period according to the authors’ method has helped to significantly reduce the inflammatory index in parturient women with pre-eclampsia.
References
Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11):845-67. doi: https://doi.org/10.1074/mcp.r200007-mcp200
Vincent JL, Russell JA, Jacob M, Martin G, Guidet B, Wernerman J, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231. doi: https://doi.org/10.1186/cc13991
Vydyborets SV. [Аlbumin of serum: the range of possibilities for the application]. Family Medicine. 2018;(2):109-17. Ukrainian. doi: https://doi.org/10.30841/2307-5112.2.2018.146190
Klygunenko O, Zozulya O. [Human serum albumin (the past and the future)]. Emergency Medicine (Ukraine). 2017;(5):26-30. Russian. doi: https://doi.org/10.22141/2224-0586.5.84.2017.109356
Cherniy VI. [The role and place of albumin in modern infusion-transfusion therapy]. Emergency Medicine (Ukraine). 2017;(1):23-31. Ukrainian. doi: https://doi.org/10.22141/2224-0586.1.80.2017.94448
Chappell D, Jacob M. Role of the glycocalyx in fluid management. Res Clin Anaesthesiol. 2014;28(3):227-34. doi: https://doi.org/10.1016/j.bpa.2014.06.003
Saner FH, Stueben BO, Hoyer DP, Broering DC, Bezinover D. Use or Misuse of Albumin in Critical Ill Patients. Diseases. 2023;11(2):68. doi: https://doi.org/10.3390/diseases11020068
Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209-90. doi: https://doi.org/10.1016/j.mam.2011.12.002
Zazzeron L, Gattinoni L, Caironi P. Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Curr Opin Crit Care. 2016;22(5):428-36. doi: https://doi.org/10.1097/MCC.0000000000000341
Evans TW. Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16 Suppl 5:6-11. doi: https://doi.org/10.1046/j.1365-2036.16.s5.2.x
Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, et al. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med. 2013 Dec;24(8):721-8. doi: https://doi.org/10.1016/j.ejim.2013.05.015
Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin – serious adverse events reported worldwide in 1998-2000. Br J Anaesth. 2003;91(5):625-30. doi: https://doi.org/10.1093/bja/aeg233
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319-34. doi: https://doi.org/10.1097/01.SLA.0000055547.93484.87
Ramador G. Infusion of albumin for seriously ill patients with COVID-19: hemodilution and anticoagulation. Int J Mol Sci. 2021;22:7126. doi: https://doi.org/10.3390/ijms22137126
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412-21. doi: https://doi.org/10.1056/NEJMoa1305727
Zhou S, Zeng Z, Wei H, Sha T, An S. Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database. Ann Intensive Care. 2021;11(1):42. doi: https://doi.org/10.1186/s13613-021-00830-8
Soussi S, Dépret F, Benyamina M, Legrand M. Early Hemodynamic Management of Critically Ill Burn Patients. Anesthesiology. 2018;129(3):583-9. doi: https://doi.org/10.1097/ALN.0000000000002314
Eljaiek R, Heylbroeck C, Dubois MJ. Albumin administration for fluid resuscitation in burn patients: A systematic review and meta-analysis. Burns. 2017;43(1):17-24. doi: https://doi.org/10.1016/j.burns.2016.08.001
Park SH, Hemmila MR, Wahl WL. Early albumin use improves mortality in difficult to resuscitate burn patients. J Trauma Acute Care Surg. 2012;73(5):1294-7. doi: https://doi.org/10.1097/TA.0b013e31827019b1
Lawrence A, Faraklas I, Watkins H, Allen A, Cochran A, Morris S, et al. Colloid administration normalizes resuscitation ratio and ameliorates "fluid creep". J Burn Care Res. 2010;31(1):40-7. doi: https://doi.org/10.1097/BCR.0b013e3181cb8c72
Weinacker A, Ang H. Guidelines for Intravenous Albumin Administration at Stanford Health Care. Stanford Health Care; 2017. 4 p.
Klygunenko OM, Sedinkin VA, Kravets OV, Marzan OO. [The effect of the inflammatory response on the development of pregnancy complicated by preeclampsia]. Pain, Anaesthesia and Intensive Care. 2024;(4):7-16. doi: Ukrainian. https://doi.org/10.25284/2519-2078.4(109).2024.318686
August P, Sibai BM. Preeclampsia: Clinical features and diagnosis. UpToDate. 2021. Available from: https://www.uptodate.com/contents/preeclampsia-clinical-features-and-diagnosis
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-60. doi: https://doi.org/10.1097/AOG.0000000000003891
Karaşin SS, Çift T. The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia. Rev Bras Ginecol Obstet. 2020;42(3):133-9. doi: https://doi.org/10.1055/s-0040-1709662
Klyhunenko OM, Volkov OO. [The interrelation of pro- and antiinflammatory cytokines in the third trimester of pregnancy]. Emergency Medicine (Ukraine). 2014;(7):131-3. Ukrainian.
Klygunenko OM, Marzan OO. [The influence of pregnancy that is complicated by preeclampsia on the main parameters of central and peripheral hemodynamics and body water compartments volume]. Ukrainian medical journal. 2021;(2):71-3. Ukrainian. doi: https://doi.org/10.32471/umj.1680-3051.142.203830
Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S895-S906. doi: https://doi.org/10.1016/j.ajog.2020.09.026
Alnaes-Katjavivi P, Roald B, Staff AC. Uteroplacental acute atherosis in preeclamptic pregnancies: Rates and clinical outcomes differ by tissue collection methods. Pregnancy Hypertens. 2020;19:1-17. doi: https://doi.org/10.1016/j.preghy.2019.11.007
Ministry of Health of Ukraine. [On approval of the Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care "Hypertensive Disorders During Pregnancy, Childbirth, and the Postpartum Period"]. Order dated 2022 Jan 24 No. 151 [Internet]. 2022 [cited 2025 Jan 2]. Available from: https://www.dec.gov.ua/wp-content/uploads/2022/01/2022_151_ykpmd_giprozlvagitn.pdf
Klygunenko OM, Kravets OV, Sedinkin VA, inventors. [Method for preventing multiple organ failure syndrome in patients with hypovolemia]. Patent 128083 Ukraine. 2018 Aug 27.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-241. doi: https://doi.org/10.1093/eurheartj/ehy340
Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019 Jul 15;366:l2381. doi: https://doi.org/10.1136/bmj.l2381
Ridder A, Giorgione V, Khalil A, Thilaganathan B. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function. Int J Mol Sci. 2019;20(13):3263. doi: https://doi.org/10.3390/ijms20133263
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 O. M. Klygunenko, O. V. Kravets, O. O. Zozulya, O. O. Marzan, Yu. O. Ploshchenko, V. A. Sedinkin, D. M. Stanin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
